Quancheng Chen, Ph.D.

Associate Professor

Experience

2009-2012Assistant Professor, Institute of Biomedical Research, Xiamen University, China

2012-presentAssociate Professor, School of Pharmaceutical Science, Xiamen University, China

Research

Dr. Chen majored in medicinal chemistry. His research interests include isolation and screening of natural products targeting nuclear receptors such as RXR and TR3 from traditional Chinese medicine, and investigation and utilization of local herb resources in Minnan district, Fujian.

Selected  Publications:

[1]Li, X.; Chen, Q.C.^#; Liu, J.; Lai, S.; Zhang, M.; Zhen, T.; Hu, H.; Gao, X.; Wong, A. S. T.; Zeng, J. Z.*, Orphan Nuclear Receptor Nur77 Mediates the Lethal Endoplasmic Reticulum Stress and Therapeutic Efficacy of Cryptomeridiol in Hepatocellular Carcinoma. Cells 2022,11 (23), 3870.

[2]Zhang, W.-Y.; Chen, H.-L.; Chen, Q.-C.*, In vitro selection of aptamer S1 against MCF-7 human breast cancer cells. Bioorganic & Medicinal Chemistry Letters 2019,29 (2019), 2393-2397.

[3]Xie, L.; Jiang, F.; Zhang, X.; Alitongbieke, G.; Shi, X.; Meng, M.; Xu, Y.; Ren, A.; Wang, J.; Cai, L.; Zhou, Y.; Xu, Y.; Su, Y.; Liu, J.; Zeng, Z.; Wang, G.; Zhou, H.; Chen, Q. C.*; Zhang, X.-K.*, Honokiol sensitizes breast cancer cells to TNF-alpha induction of apoptosis by inhibiting Nur77 expression. British Journal of Pharmacology 2016,173 (2), 344-356.

Tel: +86-135-9950-4529

Email: chenqc@xmu.edu.cn